1
|
Neumann J, Schmidtsdorff S, Schmidt AH, Parr MK. Controlling the elution order of insulin and its analogs in sub-/supercritical fluid chromatography using methanesulfonic acid and 18-crown-6 as mobile phase additives. J Sep Sci 2023; 46:e2300520. [PMID: 37775313 DOI: 10.1002/jssc.202300520] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/21/2023] [Revised: 09/05/2023] [Accepted: 09/07/2023] [Indexed: 10/01/2023]
Abstract
The purity analysis of therapeutic peptides can often be challenging, demanding the application of more than a single analytical technique. Supercritical fluid chromatography nowadays is a promising alternative to reversed-phase liquid chromatography, providing orthogonal and complementary information. This study investigated its applicability for the separation of human insulin, its analogs and degradation products. A previously published method development protocol for peptides up to 2000 Da was successfully applied to the higher molecular weight insulins (6 kDa). A single gradient method was optimized for all insulins using a Torus DEA column (100 × 3.0 mm, 1.7 μm), carbon dioxide and a modifier consisting of methanol/acetonitrile/water/methanesulfonic acid (65:35:2:0.1, v/v/v/v). Consecutively, the crown ether 18-crown-6, which is well known to complex charged lysine sidechains and other amino functionalities, was added to the modifier to evaluate its impact on selectivity. A decreased retention and a shift in the elution order for the insulins were observed. An inverse effect on retention was found when combined with a neutral stationary phase chemistry (Viridis BEH).
Collapse
Affiliation(s)
- Jonas Neumann
- Department of Biology, Chemistry, and Pharmacy, Institute of Pharmacy, Freie Universität Berlin, Berlin, Germany
- Chromicent GmbH, Berlin, Germany
| | - Sebastian Schmidtsdorff
- Department of Biology, Chemistry, and Pharmacy, Institute of Pharmacy, Freie Universität Berlin, Berlin, Germany
- Chromicent GmbH, Berlin, Germany
| | | | - Maria K Parr
- Department of Biology, Chemistry, and Pharmacy, Institute of Pharmacy, Freie Universität Berlin, Berlin, Germany
| |
Collapse
|
2
|
Peptidomics as a tool to analyze endogenous peptides in milk and milk-related peptides. FOOD BIOSCI 2022. [DOI: 10.1016/j.fbio.2022.102199] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
|
3
|
Neumann J, Schmidtsdorff S, Schmidt AH, Parr MK. Application of Sub‐/Supercritical fluid chromatography for the fingerprinting of a complex therapeutic peptide. J Sep Sci 2022; 45:3095-3104. [DOI: 10.1002/jssc.202200393] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/13/2022] [Revised: 06/17/2022] [Accepted: 07/03/2022] [Indexed: 11/10/2022]
Affiliation(s)
- Jonas Neumann
- Chromicent GmbH Johann‐Hittorf‐Str. 8 12489 Berlin Germany
- Freie Universität Berlin Königin‐Luise‐Str. 2+4 14195 Berlin Germany
| | - Sebastian Schmidtsdorff
- Chromicent GmbH Johann‐Hittorf‐Str. 8 12489 Berlin Germany
- Freie Universität Berlin Königin‐Luise‐Str. 2+4 14195 Berlin Germany
| | | | - Maria K. Parr
- Freie Universität Berlin Königin‐Luise‐Str. 2+4 14195 Berlin Germany
| |
Collapse
|
4
|
Si-Hung L, Bamba T. Current state and future perspectives of supercritical fluid chromatography. Trends Analyt Chem 2022. [DOI: 10.1016/j.trac.2022.116550] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
|
5
|
Beres M. Expanding the boundaries of SFC: Analysis of biomolecules. SEP SCI TECHNOL 2022. [DOI: 10.1016/b978-0-323-88487-7.00011-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/05/2022]
|
6
|
Yamamoto K, Machida K, Kotani A, Hakamata H. Emerging Separation Techniques in Supercritical Fluid Chromatography. Chem Pharm Bull (Tokyo) 2021; 69:970-975. [PMID: 34602578 DOI: 10.1248/cpb.c21-00306] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Supercritical fluid chromatography (SFC) has unique separative characteristics distinguished from those of HPLC and gas chromatography. At present, SFC is widely used and there are many applications in various biological, medical, and pharmaceutical fields. In this review, we focus on recently developed novel techniques related to SFC separation including: new column stationary phases, microfluidics, two-dimensional separation, and gas-liquid separation. In addition, we discuss the application of SFC using a water-containing modifier to biological molecules such as amino acids, peptides, and small proteins that had been challenging analytes.
Collapse
Affiliation(s)
- Kazuhiro Yamamoto
- Department of Analytical Chemistry, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences
| | - Koichi Machida
- Department of Analytical Chemistry, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences
| | - Akira Kotani
- Department of Analytical Chemistry, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences
| | - Hideki Hakamata
- Department of Analytical Chemistry, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences
| |
Collapse
|
7
|
Li P, Yip H, Sun D, Kempson J, Caceres-Cortes J, Mathur A, Wu DR. Sub/supercritical Fluid Chromatography Purification and Desalting of a Cyclic Dinucleotide STING Agonist. J Chromatogr A 2021; 1652:462356. [PMID: 34218126 DOI: 10.1016/j.chroma.2021.462356] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/05/2021] [Revised: 06/10/2021] [Accepted: 06/14/2021] [Indexed: 10/21/2022]
Abstract
An efficient and "endotoxin-free" purification of a cyclic dinucleotide (CDN) STING agonist was achieved to produce multigram quantities of pure BMT-390025, an active pharmaceutical ingredient (API), for toxicological studies. A two-step sub/supercritical fluid chromatography (SFC) procedure was developed for the achiral purification and desalting of the polar ionic CDN. A robust SFC process employing methanol-acetonitrile-water with ammonium acetate as co-solvent in CO2 on BEH 2-ethylpyridine was established and scaled up as the first step to achieve a successful purification. The desalting/salt-switching (i.e. removing acetate and acetamide) was conducted using methanol-water with ammonium hydroxide as co-solvent on the same column in the second step to convert the final API to the ammonium salt. Water with additive was essential to eliminating salt precipitation and improving the peak shape and resolution. Due to the extreme hydrophilicity of BMT-390025, 65% of co-solvent was needed to adequately elute the target in both steps. More than 40 g of crude API was purified and desalted producing >20 g of pure BMT-390025 as the ammonium salt which was obtained with a chemical purity of >98.5% and met the endotoxin requirement of <0.1 EU/mg. In addition, >80 g of its penultimate prior to the deprotection of the silyl group was purified at a high throughput of 6.3 g/h (0.42 g/day/g SP).
Collapse
Affiliation(s)
- Peng Li
- Department of Discovery Synthesis, Research and Early Development, Bristol Myers Squibb, Princeton, New Jersey, 08540, United States.
| | - Henry Yip
- Department of Discovery Synthesis, Research and Early Development, Bristol Myers Squibb, Princeton, New Jersey, 08540, United States.
| | - Dawn Sun
- Department of Discovery Synthesis, Research and Early Development, Bristol Myers Squibb, Princeton, New Jersey, 08540, United States
| | - James Kempson
- Department of Discovery Synthesis, Research and Early Development, Bristol Myers Squibb, Princeton, New Jersey, 08540, United States
| | - Janet Caceres-Cortes
- Department of Discovery Synthesis, Research and Early Development, Bristol Myers Squibb, Princeton, New Jersey, 08540, United States
| | - Arvind Mathur
- Department of Discovery Synthesis, Research and Early Development, Bristol Myers Squibb, Princeton, New Jersey, 08540, United States
| | - Dauh-Rurng Wu
- Department of Discovery Synthesis, Research and Early Development, Bristol Myers Squibb, Princeton, New Jersey, 08540, United States
| |
Collapse
|
8
|
Losacco GL, DaSilva JO, Liu J, Regalado EL, Veuthey JL, Guillarme D. Expanding the range of sub/supercritical fluid chromatography: Advantageous use of methanesulfonic acid in water-rich modifiers for peptide analysis. J Chromatogr A 2021; 1642:462048. [PMID: 33744606 DOI: 10.1016/j.chroma.2021.462048] [Citation(s) in RCA: 22] [Impact Index Per Article: 7.3] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/25/2021] [Revised: 03/01/2021] [Accepted: 03/02/2021] [Indexed: 11/30/2022]
Abstract
The aim of this work was to expand the applicability range of UHPSFC to series of synthetic and commercialized peptides. Initially, a screening of different column chemistries available for UHPSFC analysis was performed, in combination with additives of either basic or acidic nature. The combination of an acidic additive (13 mM TFA) with a basic stationary phase (Torus DEA and 2-PIC) was found to be the best for a series of six synthetic peptides possessing either acidic, neutral or basic isoelectric points. Secondly, methanesulfonic acid (MSA) was evaluated as a potential replacement for TFA. Due to its stronger acidity, MSA gave better performance than TFA at the same concentration level. Furthermore, the use of reduced percentages of MSA, such as 8 mM, yielded similar results to those observed with 15 mM of MSA. The optimized UHPSFC method was, then, used to compare the performance of UHPSFC against RP-UHPLC for peptides with different pI and with increasing peptide chain length. UHPSFC was found to give a slightly better separation of the peptides according to their pI values, in few cases orthogonal to that observed in UHPLC. On the other hand, UHPSFC produced a much better separation of peptides with an increased amino acidic chain compared to UHPLC. Subsequently, UHPSFC-MS was systematically compared to UHPLC-MS using a set of linear and cyclic peptides commercially available. The optimized UHPSFC method was able to generate at least similar, and in some cases even better performance to UHPLC with the advantage of providing complementary information to that given by UHPLC analysis. Finally, the analytical UHPSFC method was transferred to a semipreparative scale using a proprietary cyclic peptide, demonstrating excellent purity and high yield in less than 15 min.
Collapse
Affiliation(s)
- Gioacchino Luca Losacco
- School of Pharmaceutical Sciences, University of Geneva, CMU - Rue Michel-Servet 1, 1211 Geneva 4, Switzerland; Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, CMU - Rue Michel-Servet 1, 1211 Geneva 4, Switzerland
| | - Jimmy Oliviera DaSilva
- Analytical Research and Development, MRL, Merck & Co, Inc., 126 E. Lincoln Ave, Rahway, NJ 07065, United States
| | - Jinchu Liu
- Analytical Research and Development, MRL, Merck & Co, Inc., 126 E. Lincoln Ave, Rahway, NJ 07065, United States
| | - Erik L Regalado
- Analytical Research and Development, MRL, Merck & Co, Inc., 126 E. Lincoln Ave, Rahway, NJ 07065, United States
| | - Jean-Luc Veuthey
- School of Pharmaceutical Sciences, University of Geneva, CMU - Rue Michel-Servet 1, 1211 Geneva 4, Switzerland; Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, CMU - Rue Michel-Servet 1, 1211 Geneva 4, Switzerland
| | - Davy Guillarme
- School of Pharmaceutical Sciences, University of Geneva, CMU - Rue Michel-Servet 1, 1211 Geneva 4, Switzerland; Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, CMU - Rue Michel-Servet 1, 1211 Geneva 4, Switzerland.
| |
Collapse
|